| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Johnston John Joseph is a Director at MXCT. Recent filings cover 0 purchases and 21 sales.
Our model assigns Johnston John Joseph a strong insider score of 75/100, based on 21 past trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +29.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | MXCT Maxcyte, Inc. | Director | Sale+OE | 5,000 | $5.12 | $25,585.00 | -4.0% | -26.6% | -7.4% | |
| Dec 26, 2023 | MXCT Maxcyte, Inc. | Director | Sale+OE | 5,000 | $4.53 | $22,650.00 | -4.0% | -3.3% | -9.6% | |
| Nov 27, 2023 | MXCT Maxcyte, Inc. | Director | Sale+OE | 5,000 | $4.59 | $22,950.00 | -4.0% | -2.4% | -27.3% | |
| Nov 14, 2023 | MXCT Maxcyte, Inc. | Director | Sale+OE | 10,000 | $3.71 | $37,100.00 | -7.7% | +33.4% | -4.3% | |
| Aug 30, 2023 | MXCT Maxcyte, Inc. | Director | Sale+OE | 5,000 | $3.70 | $18,500.00 | -4.0% | +25.8% | +15.9% | |
| Jul 26, 2023 | MXCT Maxcyte, Inc. | Director | Sale+OE | 5,000 | $4.75 | $23,750.00 | -4.0% | -34.1% | -2.1% | |
| Jun 27, 2023 | MXCT Maxcyte, Inc. | Director | Sale+OE | 15,000 | $4.44 | $66,602.90 | -11.1% | -30.5% | -10.2% |